Cleave Therapeutics, Inc. Alternatives & Competitors
12 companies similar to Cleave Therapeutics, Inc. — VCP/p97 Inhibitors for Oncology and Neurodegenerative Diseases
Companies similar to Cleave Therapeutics, Inc.
Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology (Nasdaq: LIXT)
United States
Synta Pharmaceuticals
Innovating patient care with advanced small molecule therapies for severe medical conditio...
Chordia Therapeutics Inc
We are passionate to deliver first in class cancer drugs to patients from Japan.
Fujisawa, Japan
Track all Cleave Therapeutics, Inc. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Ribon Therapeutics
Pioneering Therapeutics Targeting Cellular Stress Pathways
Cambridge, United States
Amphista Therapeutics Limited
A new approach to targeted protein degradation to bring life-changing medicines to patient...
Cambridge, United Kingdom
Advenchen Laboratories, LLC
Pioneering novel therapies with promising small molecule kinase inhibitors for a brighter...
Degron Therapeutics
Aims to become a global leader in the discovery and development of molecular glue degrader...
San Diego, United States
Captor Therapeutics SA
Captor Therapeutics aims to treat cancer, infections, and diseases by targeting the diffic...
Poland
Nirogy Therapeutics
Pioneering innovative small molecules to disrupt metabolic and immune pathways, advancing...
Ambit
Driving breakthroughs in cancer and inflammatory disease treatment through pioneering kina...
Seattle, United States
About Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc., founded in 2011, is a pioneering biopharmaceutical company headquartered in the United States. It focuses on developing VCP/p97 inhibitors for applications in oncology and neurodegenerative diseases. The company positions itself as a leader in targeting the valosin-containing protein, a promi...
VCP/p97 Inhibitors, Oncology, Neurodegenerative Diseases, Biopharmaceutical, Protein Homeostasis, Cellular Stress Pathways, Cancer Stress Pathways, Drug Discovery, Drug Development, AML (Acute Myeloid Leukemia), Mitochondrial Health, Protein-Degradation Pathways, Small-Molecule Drugs, Selective Inhibitors, Therapeutic Innovation
B2B, B2G
Licensing, Project Based, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Cleave Therapeutics, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Cleave Therapeutics, Inc. on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
